Multiple Sclerosis Therapy in Dunedin
A Comprehensive Guide to MS Treatment Options and Support in New Zealand
Multiple sclerosis affects approximately 1 in 1,000 New Zealanders, with women being three times more likely to receive a diagnosis than men. While there is currently no cure for MS, modern therapeutic approaches have transformed the landscape of patient care, offering effective disease-modifying treatments that can slow progression and manage symptoms. This guide explores the comprehensive therapy options available to MS patients in Dunedin and across New Zealand.
Understanding Multiple Sclerosis
Multiple sclerosis is a chronic autoimmune condition affecting the central nervous system (brain and spinal cord). In MS, the immune system mistakenly attacks myelin—the protective coating around nerve fibres—causing inflammation, demyelination, and scarring. This disruption prevents nerves from sending normal electrical signals throughout the body.
The disease presents differently in each person. Some experience relapsing-remitting patterns with periods of attack and recovery, while others face primary progressive MS with steady worsening from onset. Symptoms vary widely and may include fatigue, mobility challenges, cognitive issues, vision problems, and pain.
Key Fact: Early diagnosis and prompt initiation of disease-modifying therapy (DMT) can significantly slow progression and reduce long-term disability, making it crucial to seek specialist care quickly.
Disease-Modifying Therapies Available in New Zealand
New Zealand’s health system, through Pharmac (Pharmaceutical Management Agency), funds several disease-modifying treatments designed to reduce relapses and slow disability progression. These medications work by modulating the immune response.
💊
Interferon Beta
Interferon beta-1a and beta-1b are immune-modulating agents approved for relapsing-remitting MS. They reduce inflammation and decrease relapse frequency by up to 30%.
🛡️
Glatiramer Acetate
An immunomodulatory drug that helps prevent relapses in relapsing-remitting MS. It’s administered via injection and has a well-established safety profile.
🔄
Ocrelizumab (Ocrevus)
The first DMT approved for primary progressive MS, Ocrelizumab targets CD20-positive B cells and is administered intravenously twice yearly, marking a major breakthrough in progressive MS treatment.
Access to Treatments
Subsidised disease-modifying treatments in New Zealand require application from a neurologist to the Multiple Sclerosis Treatment Assessments Committee. Approval criteria typically include evidence of frequent relapses and significant residual disability. Medications are delivered directly to patients or clinicians rather than through traditional pharmacies, ensuring continuity of care.
Advanced Therapeutic Options
Stem Cell Transplantation (aHSCT)
Autologous hematopoietic stem cell transplantation (aHSCT) is an emerging intensive therapy now available in New Zealand for select patients. This highly specialised treatment involves harvesting the patient’s own stem cells, chemically conditioning the immune system, and reinfusing the cells.
While invasive and requiring careful monitoring, aHSCT has demonstrated the ability to halt or significantly slow disease progression in some patients, particularly those with active, aggressive MS. Your neurologist can assess whether this option is appropriate for your individual case.
Clinical Trial Participation
Dunedin is an active research centre for multiple sclerosis. The O-Hand trial (Oratorio-Hand) is currently recruiting participants with primary progressive MS at Dunedin DHB. This global clinical study investigates new therapeutic approaches and offers access to cutting-edge treatments not yet widely available.
Research Opportunity: Clinical trial participation can provide early access to emerging therapies while contributing to MS research that benefits future patients globally.
Comprehensive MS Management
Effective MS care extends beyond medication alone. A multidisciplinary approach addressing physical, cognitive, and emotional aspects produces the best outcomes.
Rehabilitation and Therapy Services
- Physiotherapy: Helps maintain strength, balance, and mobility while managing fatigue and spasticity
- Occupational Therapy: Provides strategies for managing daily activities and maintaining independence
- Speech and Cognitive Therapy: Addresses communication and cognitive challenges when relevant
- Mental Health Support: Essential for managing depression and anxiety, which commonly accompany MS
- Lifestyle Modifications: Nutrition, exercise, stress management, and sleep optimisation
Lifestyle Approaches
Many people with MS benefit from complementary approaches including yoga, mindfulness, acupuncture, massage, and dietary modifications. While these cannot replace disease-modifying medications, they can significantly enhance quality of life. Some patients find success with structured programs like “Overcoming Multiple Sclerosis” which combines lifestyle factors with conventional treatment.
MS Support & Resources in Dunedin
🏥 Otago MS Society
Address: 43 Princes Street, Dunedin
Phone: +64 3-455 5894
Email: admin@msotago.org.nz
Website: msotago.org.nz
🌐 Multiple Sclerosis Society of NZ
National support and advocacy organisation providing information, resources, and community support
Website: msnz.org.nz
⚕️ Dunedin Hospital
Access neurology services and MS specialist care through the public health system
Referral through your general practitioner
Getting Started with MS Therapy
Your Treatment Journey
- GP Consultation: Begin with your general practitioner if you have symptoms suggestive of MS
- Neurology Referral: Your GP will refer you to a neurologist for comprehensive assessment and diagnosis
- Disease Assessment: Your neurologist will determine your MS type and disease activity
- Treatment Plan: Discuss treatment options, side effects, and your personal preferences
- Multidisciplinary Care: Access physiotherapy, occupational therapy, and support services as needed
- Ongoing Monitoring: Regular follow-up appointments to assess treatment effectiveness and side effects
Take the First Step
If you’re experiencing symptoms or seeking better MS management, contact the Otago MS Society or your healthcare provider to explore your treatment options.Get Support Today
Common Questions About MS Therapy
When should MS treatment start?
Early intervention is key. Disease-modifying therapy should ideally begin shortly after diagnosis, even if symptoms are mild. Early treatment helps prevent accumulation of disability over time.
Are there side effects with these treatments?
All medications carry potential side effects. Most MS therapies are well-tolerated, though patients may experience mild flu-like symptoms, injection site reactions, or other effects. Your neurologist will discuss these thoroughly and monitor your response to treatment.
Can MS therapy be stopped or changed?
Treatment decisions are ongoing. If a medication isn’t working well or side effects become problematic, your neurologist may recommend switching to an alternative therapy. This requires careful planning and monitoring.
How do I access clinical trials?
Ask your neurologist about available clinical trials. Dunedin DHB participates in international MS research. Trials offer access to emerging therapies and contribute valuable data for MS research advancement.
Looking Forward
The landscape of multiple sclerosis therapy has transformed dramatically over the past decade. From disease-modifying medications to advanced stem cell therapies and clinical trials exploring novel approaches, individuals with MS in Dunedin have access to world-class treatment options.
The key to successful MS management is early diagnosis, prompt initiation of appropriate therapy, and comprehensive multidisciplinary care combining medical treatment with rehabilitation, lifestyle optimisation, and emotional support.
Whether you’re newly diagnosed or seeking to optimise existing treatment, the Otago MS Society and Dunedin’s healthcare professionals are equipped to guide your journey toward maintaining function, independence, and quality of life with multiple sclerosis.